Published in Eur J Pediatr on January 26, 1977
Metabolism and possible health effects of aluminum. Environ Health Perspect (1986) 1.64
Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets. Clin Exp Immunol (1984) 1.08
Immunodeficiency in Down's syndrome: T-lymphocyte subset imbalance in trisomic children. Clin Exp Immunol (1978) 1.00
Natural killer cell function in trisomy-21 (Down's syndrome). Clin Exp Immunol (1982) 0.88
Inflammatory and Immunological parameters in adults with Down syndrome. Immun Ageing (2011) 0.85
Immune function in patients with chromosome deletions. Clin Exp Immunol (1982) 0.75
T cell response to anti-CD3 antibody in Down's syndrome. Arch Dis Child (1987) 0.75
Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J (1996) 4.26
Multiple components in an epidermal growth factor-stimulated protein kinase cascade. In vitro activation of a myelin basic protein/microtubule-associated protein 2 kinase. J Biol Chem (1991) 3.81
ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J (1996) 3.22
Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Genet (1997) 2.93
In situ activation pattern of Drosophila EGF receptor pathway during development. Science (1997) 2.56
MAP kinase in situ activation atlas during Drosophila embryogenesis. Development (1997) 2.55
Selective requirement for MAP kinase activation in thymocyte differentiation. Nature (1995) 2.53
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood (2001) 2.50
Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. Proc Natl Acad Sci U S A (1999) 2.29
Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr (1989) 2.22
Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci U S A (1995) 2.18
The mitogen-activated protein kinase activator. Curr Opin Cell Biol (1992) 2.14
Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells. J Biol Chem (1995) 1.95
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene (2001) 1.95
Secreted Spitz triggers the DER signaling pathway and is a limiting component in embryonic ventral ectoderm determination. Genes Dev (1995) 1.91
Nuclear translocation of mitogen-activated protein kinase kinase (MEK1) in response to mitogenic stimulation. Proc Natl Acad Sci U S A (1997) 1.72
Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type 1-infected infants. Swiss Neonatal HIV Study Group. J Infect Dis (1994) 1.69
Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function. J Biol Chem (1999) 1.60
Dissecting the roles of the Drosophila EGF receptor in eye development and MAP kinase activation. Development (1998) 1.53
Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor. Trends Endocrinol Metab (2000) 1.49
Specific and differential activation of mitogen-activated protein kinase cascades by unfamiliar taste in the insular cortex of the behaving rat. J Neurosci (1998) 1.44
Protective effect of aprotinin on ischemic hepatocellular damage. Transplantation (1989) 1.42
Repeated pulses of serotonin required for long-term facilitation activate mitogen-activated protein kinase in sensory neurons of Aplysia. Proc Natl Acad Sci U S A (1998) 1.37
Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. Eur J Immunol (2001) 1.30
Fibroblast growth factor (FGF) signaling through PI 3-kinase and Akt/PKB is required for embryoid body differentiation. Oncogene (2000) 1.27
Hippocampal plasticity involves extensive gene induction and multiple cellular mechanisms. J Mol Neurosci (1998) 1.27
Identification of a cytoplasmic-retention sequence in ERK2. J Biol Chem (1999) 1.24
Detection of ERK activation by a novel monoclonal antibody. FEBS Lett (1997) 1.22
Fibroblast growth factor promotes recruitment of skeletal muscle satellite cells in young and old rats. J Histochem Cytochem (1999) 1.22
ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network. Mol Cell Biol (1998) 1.19
Retracted Involvement of the activation loop of ERK in the detachment from cytosolic anchoring. J Biol Chem (2001) 1.14
Potential hazards of blood-transfusion in Clostridia-associated necrotising enterocolitis. Lancet (1979) 1.11
Progress and prospects: gene therapy clinical trials (part 1). Gene Ther (2007) 1.09
The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable. Bone Marrow Transplant (2007) 1.06
The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing. EMBO J (1999) 1.06
Metabolic labeling of mitogen-activated protein kinase kinase in A431 cells demonstrates phosphorylation on serine and threonine residues. Proc Natl Acad Sci U S A (1993) 1.05
Juvenile chronic arthritis: imaging of the knees and hips before and after intraarticular steroid injection. Pediatr Radiol (1994) 1.05
Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary alpha T3-1 cell line is mediated by protein kinase C, c-Src, and CDC42. Mol Endocrinol (1998) 1.03
Wiskott-Aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product. Hum Genet (1996) 1.02
Deficiency of the adhesive protein complex lymphocyte function antigen 1, complement receptor type 3, glycoprotein p150,95 in a girl with recurrent bacterial infections. Effects on phagocytic cells and lymphocyte functions. J Clin Invest (1985) 1.01
Detection of partially phosphorylated forms of ERK by monoclonal antibodies reveals spatial regulation of ERK activity by phosphatases. FEBS Lett (2000) 1.01
Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor. Arch Med Res (2001) 1.00
Non-regulated and stimulated mechanisms cooperate in the nuclear accumulation of MEK1. Oncogene (2001) 1.00
Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor. Mol Cell Biol (1999) 1.00
Retracted Role of dynamin, Src, and Ras in the protein kinase C-mediated activation of ERK by gonadotropin-releasing hormone. J Biol Chem (2000) 1.00
The MAP kinase cascade. Recent Prog Horm Res (1995) 0.99
Cervical abscess due to Capnocytophaga ochracea. Pediatr Infect Dis (1983) 0.99
Gene deletion in a patient with chronic granulomatous disease and McLeod syndrome: fine mapping of the Xk gene locus. Blood (1988) 0.99
Retracted ERK1b, a 46-kDa ERK isoform that is differentially regulated by MEK. J Biol Chem (2000) 0.98
Identification of an activator of the microtubule-associated protein 2 kinases ERK1 and ERK2 in PC12 cells stimulated with nerve growth factor or bradykinin. J Neurochem (1992) 0.97
The management of chronic granulomatous disease. Eur J Pediatr (1993) 0.97
Identification of an inducible 85-kDa nuclear protein kinase. J Biol Chem (1993) 0.97
Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland. Bone Marrow Transplant (2006) 0.96
Uptake, intracellular activity, and influence of rifampin on normal function of polymorphonuclear leukocytes. Antimicrob Agents Chemother (1985) 0.96
Overexpressed tau protein in cultured cells is phosphorylated without formation of PHF: implication of phosphoprotein phosphatase involvement. Brain Res Mol Brain Res (1995) 0.96
Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis. Clin Exp Immunol (2001) 0.95
Co-stimulation-dependent activation of a JNK-kinase in T lymphocytes. Eur J Immunol (1998) 0.94
Continual observation of clinical and immunological parameters, in particular of salivary IgA, in tonsillectomised children. Arch Otorhinolaryngol (1980) 0.94
Effects of phorbol ester on mitogen-activated protein kinase kinase activity in wild-type and phorbol ester-resistant EL4 thymoma cells. J Biol Chem (1993) 0.94
LIS1 is a microtubule-associated phosphoprotein. Eur J Biochem (1999) 0.94
Hemolytic-uremic syndrome associated with neuraminidase-producing microorganisms: treatment by exchange transfusion. Helv Paediatr Acta (1980) 0.93
Retracted Altered regulation of ERK1b by MEK1 and PTP-SL and modified Elk1 phosphorylation by ERK1b are caused by abrogation of the regulatory C-terminal sequence of ERKs. J Biol Chem (2001) 0.93
Protein truncation test of LYST reveals heterogenous mutations in patients with Chediak-Higashi syndrome. Blood (2000) 0.93
Expression of MHC class II molecules contributes to lipopolysaccharide responsiveness. Eur J Immunol (2000) 0.92
Mechanism of mitogen-activated protein kinase activation by gonadotropin-releasing hormone in the pituitary of alphaT3-1 cell line: differential roles of calcium and protein kinase C. Endocrinology (1997) 0.92
Cytochrome b558-negative, autosomal recessive chronic granulomatous disease: two new mutations in the cytochrome b558 light chain of the NADPH oxidase (p22-phox). Am J Hum Genet (1992) 0.92
The CK2 phosphorylation of vitronectin. Promotion of cell adhesion via the alpha(v)beta 3-phosphatidylinositol 3-kinase pathway. J Biol Chem (2001) 0.91
Registry of primary immunodeficiencies in Switzerland. Immunodeficiency (1993) 0.91
Evaluation of diagnostic tests for HIV infection in infants born to HIV-infected mothers in Switzerland. AIDS (1988) 0.90
Interferon gamma for chronic granulomatous disease. N Engl J Med (1991) 0.90
Cutting edge: extracellular signal-regulated kinase activates syk: a new potential feedback regulation of Fc epsilon receptor signaling. J Immunol (1999) 0.89
Gi-mediated activation of mitogen-activated protein kinase (MAPK) pathway by receptor mimetic basic secretagogues of connective tissue-type mast cells: bifurcation of arachidonic acid-induced release upstream of MAPK. J Pharmacol Exp Ther (1999) 0.89
The PI3K inhibitor LY294002 prevents p53 induction by DNA damage and attenuates chemotherapy-induced apoptosis. Cell Death Differ (2005) 0.88
IgG-subclass concentrations in cord sera from premature, full term and small-for-dates babies. Eur J Pediatr (1977) 0.88
Necrotising enterocolitis and neuraminidase-producing bacteria. Helv Paediatr Acta (1980) 0.88
In vitro phosphorylation of COOH termini of the epithelial Na(+) channel and its effects on channel activity in Xenopus oocytes. Am J Physiol Renal Physiol (2001) 0.88
Signal transduction of the gonadotropin releasing hormone (GnRH) receptor: cross-talk of calcium, protein kinase C (PKC), and arachidonic acid. Cell Mol Neurobiol (1995) 0.87
A family with whistling-face-syndrome. Hum Genet (1980) 0.87
Growth factor-stimulated phosphorylation cascades: activation of growth factor-stimulated MAP kinase. Ciba Found Symp (1992) 0.87
Tx, a "new" red cell cryptantigen exposed by pneumococcal enzymes. Rev Fr Transfus Immunohematol (1982) 0.87
The cytoskeletal network controls c-Jun expression and glucocorticoid receptor transcriptional activity in an antagonistic and cell-type-specific manner. Mol Cell Biol (1999) 0.87
Hyperglycemia reduces nitric oxide synthase and glycogen synthase activity in endothelial cells. Nitric Oxide (2002) 0.86
Clinical and cytogenetic observations during a six-year period in an adult with Fanconi's anaemia. Blut (1977) 0.86
Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells. Hum Gene Ther (1998) 0.85
Effect of different nitroheterocyclic compounds on aerobic, microaerophilic, and anaerobic bacteria. Antimicrob Agents Chemother (1986) 0.85
GRFbeta, a novel regulator of calcium signaling, is expressed in pancreatic beta cells and brain. J Biol Chem (1999) 0.84
Mechanism of GnRH receptor signaling on gonadotropin release and gene expression in pituitary gonadotrophs. Vitam Horm (2001) 0.83
PGE2 up-regulates EGF-like growth factor biosynthesis in human granulosa cells: new insights into the coordination between PGE2 and LH in ovulation. Mol Hum Reprod (2006) 0.83
Hepatitis types A, B, and non A--non B in childhood. Eur J Pediatr (1979) 0.83
Mechanism of GnRH receptor signaling: from the membrane to the nucleus. Ann Endocrinol (Paris) (1999) 0.83
CPG16, a novel protein serine/threonine kinase downstream of cAMP-dependent protein kinase. J Biol Chem (1999) 0.82
Evaluation of phagocytosis in rickets. Acta Paediatr Scand (1970) 0.82
Unknown syndrome: ischiadic hypoplasia, renal dysfunction, immunodeficiency, and a pattern of minor congenital anomalies. J Med Genet (1991) 0.82
BMP-4 regulates the dorsal-ventral differences in FGF/MAPKK-mediated mesoderm induction in Xenopus. Dev Biol (1995) 0.82
The frequency of pretransplant donor cytotoxic T cell precursors with anti-host specificity predicts survival of patients transplanted with bone marrow from donors other than HLA-identical siblings. Transplantation (1993) 0.82
[Studies on the antimicrobial effect of vitamin D (author's transl)]. Klin Wochenschr (1977) 0.81